Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Download Issue
In troubled markets, it’s rare to find a company that offers the right mix between safety and potential growth. For 2016, the one stock to own is Novo Nordisk, which became an active EBIS portfolio component on 12/21/15. We didn’t make this choice lightly, especially at a time of rising… Read More
In troubled markets, it’s rare to find a company that offers the right mix between safety and potential growth. For 2016, the one stock to own is Novo Nordisk, which became an active EBIS portfolio component on 12/21/15. We didn’t make this choice lightly, especially at a time of rising… Read More
[from the 01/11/2016 edition of Smart Tech 50 Weekly Movers]With the stock market reeling from last week’s currency devaluation out of China, we are closing out several positions to decrease exposure to reduce risk until there is further clarity. We are selling the following the stocks out of the… Read More
[from the 01/11/2016 edition of Smart Tech 50 Weekly Movers]With the stock market reeling from last week’s currency devaluation out of China, we are closing out several positions to decrease exposure to reduce risk until there is further clarity. We are selling the following the stocks out of the… Read More
Download Issue
The week of December 21, 2015 promises to be significant for our “EBIS” and “Trading” portfolios as last week’s action in the markets shook things up a bit. Read More
The week of December 21, 2015 promises to be significant for our “EBIS” and “Trading” portfolios as last week’s action in the markets shook things up a bit. Read More
[from today’s edition of Smart Tech 50 Weekly Movers]We are adding three new trading opportunities to the STI Medical Profits Portfolio, as follows:Invacare (IVC): Invacare makes hospital beds, electric wheelchairs and related devices. The stock looks poised for a breakout. It fails to make the EBIS cut based on… Read More
[from today’s edition of Smart Tech 50 Weekly Movers]We are adding three new trading opportunities to the STI Medical Profits Portfolio, as follows:Invacare (IVC): Invacare makes hospital beds, electric wheelchairs and related devices. The stock looks poised for a breakout. It fails to make the EBIS cut based on… Read More
[from the 11/16/2015 issue of Smart Tech Investor]Cerus Corp. is a tiny, $550 million market capitalization stock that is well stocked with cash, has an interesting pipeline and is in the difficult stage of development where it is pushing for market share in the United States while struggling with the… Read More
[from the 11/16/2015 issue of Smart Tech Investor]Cerus Corp. is a tiny, $550 million market capitalization stock that is well stocked with cash, has an interesting pipeline and is in the difficult stage of development where it is pushing for market share in the United States while struggling with the… Read More